- Home
- ANTX vs CTM Comparison
ANTX vs CTM Comparison
Compare ANTX & CTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANTX | CTM |
|---|---|---|
| Founded | 2017 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.6M | 93.7M |
| IPO Year | 2022 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ANTX | CTM |
|---|---|---|
| Price | $3.00 | $0.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.00 | ★ $3.00 |
| AVG Volume (30 Days) | 361.2K | ★ 1.3M |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 32.56 | ★ 83.33 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $52,866,001.00 |
| Revenue This Year | N/A | $20.36 |
| Revenue Next Year | N/A | $6.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.10 |
| 52 Week Low | $1.00 | $0.48 |
| 52 Week High | $6.91 | $1.56 |
Technical Indicators
Market Signals| Indicator | ANTX | CTM |
|---|---|---|
| Relative Strength Index (RSI) | 44.38 | 45.78 |
| Support Level | $1.06 | $0.48 |
| Resistance Level | $6.91 | $1.21 |
| Average True Range (ATR) | 0.35 | 0.06 |
| MACD | -0.16 | 0.01 |
| Stochastic Oscillator | 8.97 | 88.00 |
Price Performance
Historical ComparisonAbout ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
About CTM Castellum Inc.
Castellum Inc is engaged in providing information technology services. The company provides financial services, healthcare, and other users of large data applications with services that include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and MBSE. In addition to constantly innovating and enhancing organic capabilities, Castellum is acquiring technology companies in the areas of cybersecurity, information technology, electronic warfare, information warfare, and information operations with businesses in the defense, federal, civilian, and commercial markets.